Literature DB >> 35121999

PROactively TACkling CDK4/6 therapy resistance.

Signe Caksa1, Andrew E Aplin2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 35121999     DOI： 10.1038/s43018-021-00193-w

Source DB:  PubMed          Journal:  Nat Cancer        ISSN： 2662-1347


× No keyword cloud information.
  1 in total

1.  Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy.

Authors:  Robert M Samstein; Chirag Krishna; Xiaoxiao Ma; Xin Pei; Ken-Wing Lee; Vladimir Makarov; Fengshen Kuo; Jonathan Chung; Raghvendra M Srivastava; Tanaya A Purohit; Douglas R Hoen; Rajarsi Mandal; Jeremy Setton; Wei Wu; Rachna Shah; Besnik Qeriqi; Qing Chang; Sviatoslav Kendall; Lior Braunstein; Britta Weigelt; Pedro Blecua Carrillo Albornoz; Luc G T Morris; Diana L Mandelker; Jorge S Reis-Filho; Elisa de Stanchina; Simon N Powell; Timothy A Chan; Nadeem Riaz
Journal:  Nat Cancer       Date:  2020-11-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.